News and Announcements
CEO Dr James Garner featured on ‘The Health Kick Podcast’ to discuss the company’s latest achievements
- Published October 16, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Kazia CEO, Dr James Garner was recently featured on Stockhead’s new podcast series, “The Health Kick Podcast” with Tim Boreham.
In the interview, Dr Garner discusses:
- The company’s journey from Novogen to Kazia and building a world-class, 21st century drug developer
- Kazia’s recent achievements and milestones, including the company’s win of an inaugural ANZLF Trans-Tasman Innovation and Growth Award
- The blood brain barrier and how Kazia’s lead candidate, GDC-0084, treats glioblastoma, the most aggressive form of brain cancer
Kazia will be presenting at the upcoming Australia Biotech Invest & Partnering conference on Thursday 31 October at the Melbourne Convention and Exhibition Centre.
For more information on Kazia register your interest below.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
